Ataraxis AI is a precision medicine company developing AI-powered diagnostic tools to improve cancer treatment selection and patient outcomes, starting with its flagship product, Ataraxis Breast.
Transforming cancer care at all stages of the disease.
Veracyte, Inc. is a global diagnostics company dedicated to revolutionizing cancer care through innovative genomic testing solutions.
PAWe're building next generation computational technology that unlocks insights from each sample for doctors to optimize patient outcomes.
GRAIL is a healthcare company focused on detecting cancer early, when it can be cured, through the development and commercialization of pioneering multi-cancer early detection blood tests like Galleri®.
Dendreon is dedicated to personalized cancer treatment and has made significant advancements with its FDA-approved immunotherapy, Provenge.